Welcome to our dedicated page for Aquabounty Technologies news (Ticker: AQB), a resource for investors and traders seeking the latest updates and insights on Aquabounty Technologies stock.
AquaBounty Technologies, Inc. (NASDAQ: AQB) generates a steady flow of disclosures and news centered on land-based aquaculture, restructuring of farm assets, and corporate financing. As a company that describes itself as a pioneer in land-based recirculating aquaculture system ("RAS") farms and biotechnology-driven fish breeding and genetics, its news releases provide insight into how it is adapting its operations, balance sheet, and capital structure.
Recent AquaBounty news has focused heavily on financial results, including quarterly and full-year earnings releases that detail net income or loss, asset impairment charges, discontinued operations, and cash balances. These reports explain the financial impact of selling the Indiana grow-out farm, winding down Canadian farm sites, and classifying those operations as discontinued, as well as the sale of equipment associated with the partially constructed Ohio Farm Project.
Another key theme in AquaBounty’s news is the wind down of active farming operations. In December 2024, the company announced plans to cease fish farming at its Bay Fortune hatchery, described as its only remaining operating farm, citing liquidity constraints. Subsequent updates in 2025 describe the sale of its Canadian subsidiary, including broodstock farms and corporate intellectual property related to genetically engineered Atlantic salmon, and multiple sales of Ohio equipment assets.
Corporate finance and governance developments also feature prominently. AquaBounty’s news and related 8-K filings discuss a bridge loan secured by farm assets, the issuance of unsecured senior notes in a private placement, and associated changes in board composition and potential change in control. The company has also reported on Nasdaq listing compliance, including the resolution of a minimum bid price deficiency.
Investors and observers following AQB news can expect coverage of earnings announcements, asset sales and impairments, strategic alternatives for the Ohio Farm Project, financing arrangements, and board and management changes. Monitoring this news stream helps contextualize the company’s evolving aquaculture footprint, balance sheet, and strategic direction.
AquaBounty Technologies (AQB) announced its financial results for Q1 2021, achieving a revenue of $74,000, up from $7,000 in Q1 2020, despite pandemic-related challenges. The company reported a net loss of $4.2 million, compared to $3.1 million the previous year. AquaBounty raised $127.1 million through a public offering in February to finance the construction of Farm 3, which will increase production capacity. With new sales director Dennis Bryant on board, the company is set to launch its genetically engineered salmon commercially in May 2021, following positive customer feedback and a resurgence in the food service industry.
AquaBounty Technologies has appointed Dennis Bryant as its new Director of Sales, leveraging his extensive experience in seafood sales to enhance customer partnerships ahead of the commercial launch of its genetically engineered Atlantic salmon in the U.S. and Canada. Previously the Managing Director at Ocean Quality USA, Bryant will optimize AquaBounty's supply chain and manage relationships with processing partners and freight carriers. This strategic hire is expected to strengthen AquaBounty's market position and improve order fulfillment and customer satisfaction.
AquaBounty Technologies reported its Q4 and 2020 year-end financial results, showcasing a revenue increase to $50,197 compared to $46,367 in Q4 2019. The company achieved $192.3 million in gross proceeds from public offerings, enhancing its balance sheet for the development of a 10,000 metric ton farm. Operational costs rose to $6.1 million due to increased production. The company faced a net loss of $6.1 million and inventory reserves of $1.5 million due to conventional salmon donations. AquaBounty anticipates a positive 2021, driven by rising consumer demand and planned commercial activities.
Summary not available.
AquaBounty Technologies, Inc. (AQB) has successfully completed an underwritten public offering of 14,950,000 shares at $8.50 per share, raising approximately $127.1 million. This figure includes the full exercise of an option for underwriters to purchase an additional 1,950,000 shares. The net proceeds will be allocated to general corporate purposes, including establishing a new production farm and bolstering sales, marketing, and R&D initiatives. Oppenheimer & Co. Inc. and Lake Street Capital Markets acted as joint book-running managers for this offering.
AquaBounty Technologies (Nasdaq: AQB) announced a public offering of 13 million shares at $8.50 each, aiming for approximately $110.5 million in gross proceeds. The offering, expected to close by February 8, 2021, includes a 30-day option for underwriters to purchase an additional 1.95 million shares. Proceeds will fund general corporate purposes, including new farm construction and R&D investments. Oppenheimer & Co. and Lake Street Capital Markets are leading the offering. A registration statement was filed with the SEC and is effective as of January 25, 2021.
AquaBounty Technologies (Nasdaq: AQB) has started an underwritten public offering of its common stock, with underwriters expecting a 30-day option to purchase more shares. The offering's success is contingent on market conditions. The funds are intended for general corporate purposes, including development of a new production farm and enhancements in sales, marketing, and R&D. A registration statement for this offering was filed with the SEC and declared effective on January 25, 2021. No assurance is provided regarding the offering's completion or terms.
AquaBounty Technologies (NASDAQ: AQB) has successfully closed an underwritten public offering of 10,028,000 common shares at $6.50 each, generating approximately $65.2 million in gross proceeds. The offering included the exercise of underwriters' option for an additional 1,308,000 shares. The funds are intended for general corporate purposes, including land acquisition, construction costs for a new production farm, and increased investment in sales, marketing, and R&D. The offering was managed by Oppenheimer & Co. Inc. and Lake Street Capital Markets.
AquaBounty Technologies (Nasdaq: AQB) has announced a public offering of 8,720,000 shares at $6.50 per share, aiming to raise approximately $56.7 million. The offering is expected to close around December 14, 2020. The funds will be used for general corporate purposes, including land acquisition, construction of a new production farm, and enhancing sales, marketing, and R&D. The company granted underwriters a 30-day option for an additional 1,308,000 shares. The offering is part of AquaBounty's strategy to increase productivity in land-based aquaculture.
AquaBounty Technologies (NASDAQ: AQB) has selected Innovasea as the Recirculating Aquaculture Systems (RAS) technology provider for its upcoming 10,000 metric ton farm, known as Farm 3. The total build cost is projected to range from $140 million to $175 million, with construction expected to start in 2021 and production anticipated by 2023. AquaBounty is exploring optimal locations for Farm 3 within Kentucky and the Midwest. The CEO emphasizes a commitment to operational milestones and the first harvest of AquAdvantage salmon, promising continued updates for shareholders.